NCT07452068

Brief Summary

Various approach has outlined in the literature but no clinical studies that have compared the intrasinus and extrasinus approach for the placement of zygomatic implants using zygomatic success code. The present study is planned to compare the intrasinus and extrasinus approach for the placement of zygomatic implant in severely resorbed edentulous maxillary arch using zygomatic success code.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 4, 2025

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
Last Updated

March 5, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 4, 2025

Last Update Submit

March 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Zygomatic implant stability

    When extra-sinus and intra-sinus placed implants are tested individually, slight mobility should be detected with no other associated pathological signs. Instrument used for checking the implant stability is periotest. Mobility of the implant comes from the elastic modulus of the anchoring zygomatic bone when they are bent by a remotely applied force. On the other hand, the movement must not be rotational, and it will disappear when implants are splinted together. A rotational movement should be considered as a sign of implant failure. Grade I- no mobility, no pain Grade II-light clinical mobility, no pain Grade III-clear clinical mobility, no pain (no evidence of disintegration of the apical part of the implant or rotation Grade IV- clear clinical mobility, rotation and pain evidence of disintegration of apical part of the implant)

    Implant stability was evaluated individually after 3 and 6 months of implant placement and prosthetic rehabilitation

Secondary Outcomes (3)

  • Associated sinus pathology

    Associated sinus pathologywas assessed at 3 and 6 months after implant placement

  • Peri-Implant Soft Tissue Condition

    Soft tissue around the zygomatic implant was assessed at 3 and 6 months

  • Prosthetic Offset

    Prosthetic Offset assessed at 3 and 6 months

Study Arms (2)

INTRASINUS

EXPERIMENTAL

PARAMETERS ASSESED: 1. IMPLANT STABILITY 2. SINUS PATHOLOGY 3. SOFT TISSUE CONDITIONING 4. PROSTHETIC OFFSET 18 SAMPLES INCLUDED

Procedure: ZYGOMATIC IMPLANT KIT

EXTRASINUS

ACTIVE COMPARATOR

PARAMETERS ASSESED: 1. IMPLANT STABILITY 2. SINUS PATHOLOGY 3. SOFT TISSUE CONDITIONING 4. PROSTHETIC OFFSET 18 SAMPLES INCLUDED

Procedure: ZYGOMATIC IMPLANT KIT

Interventions

CRESTAL INCISION FROM TUBEROSITY TO TUBEROSITY AND REFLECT THE FLAP . OSTEOTOMY DONE FROM MOLAR TO ZYGOMATIC BONE.IMPLANT PLACEMENT DONE

EXTRASINUSINTRASINUS

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Completely edentulous maxilla.
  • Both gender without any systemic disease.
  • Patients with Misch-Type III edentulous maxillary arch and with Seibert's Class III ridge.
  • ZAGA-4 patients (pronounced buccal concavities of the maxilla).

You may not qualify if:

  • Any systemic illness/medications
  • Radiation therapy to the head and neck region 12 months prior to the proposed therapy.
  • Smoking
  • Pregnant and lactating women
  • Drug allergy
  • Bisphosphonates medication
  • Alcohol/ drug addiction
  • Maxillary sinusitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2025

First Posted

March 5, 2026

Study Start

March 31, 2023

Primary Completion

April 25, 2024

Study Completion

December 26, 2024

Last Updated

March 5, 2026

Record last verified: 2026-02

Locations